Pages that link to "Q58674935"
Jump to navigation
Jump to search
The following pages link to Elena Jachetti (Q58674935):
Displaying 22 items.
- iNKT cells control mouse spontaneous carcinoma independently of tumor-specific cytotoxic T cells (Q33523809) (← links)
- Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers (Q36782301) (← links)
- Prostate cancer stem cells are targets of both innate and adaptive immunity and elicit tumor-specific immune responses (Q36887869) (← links)
- Antisense transcription at the TRPM2 locus as a novel prognostic marker and therapeutic target in prostate cancer. (Q38984564) (← links)
- Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation. (Q39025315) (← links)
- Characterization of preclinical models of prostate cancer using PET-based molecular imaging (Q39874026) (← links)
- Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNgamma (Q39906069) (← links)
- Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial-Stromal Tumors by Targeting PDGFR-β. (Q40408079) (← links)
- Immunosuppression via Tenascin-C (Q40971410) (← links)
- Modulators of arginine metabolism do not impact on peripheral T-cell tolerance and disease progression in a model of spontaneous prostate cancer. (Q43841124) (← links)
- Prolonged exposure of dendritic cells to maturation stimuli favors the induction of type-2 cytotoxic T lymphocytes. (Q45863881) (← links)
- Peripheral T-cell tolerance associated with prostate cancer is independent from CD4 CD25 regulatory T cells (Q45874119) (← links)
- Vasculature-targeted tumor necrosis factor-alpha increases the therapeutic index of doxorubicin against prostate cancer (Q45877037) (← links)
- Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. (Q54510441) (← links)
- Targeting TNF- to Neoangiogenic Vessels Enhances Lymphocyte Infiltration in Tumors and Increases the Therapeutic Potential of Immunotherapy (Q57950933) (← links)
- Concomitant Tumor and Minor Histocompatibility Antigen–Specific Immunity Initiate Rejection and Maintain Remission from Established Spontaneous Solid Tumors (Q58882220) (← links)
- Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer (Q88012879) (← links)
- Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma (Q89633512) (← links)
- Infiltrating mast cell-mediated stimulation of estrogen receptor activity in breast cancer cells promotes the luminal phenotype (Q90369537) (← links)
- Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity (Q92002554) (← links)
- Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma (Q112614414) (← links)
- The evolutionarily conserved long non-coding RNA LINC00261 drives neuroendocrine prostate cancer proliferation and metastasis via distinct nuclear and cytoplasmic mechanisms (Q112756045) (← links)